Apollo expands its growth ecosystem by acquiring a minority stake in pioneering life sciences venture capital firm and providing up to €1 billion of capital commitments Sofinnova Partners poised to accelerate growth with additional capital and global...
WASHINGTON--(BUSINESS WIRE)--#AR--Altoida, a pioneer in non-invasive brain health measurement and neurological disease diagnostics using AI and augmented reality (AR), today announced it has joined the Digital Medicine Society’s (DiMe) Alzheimer’s Dise...
HAYWARD, Calif.--(BUSINESS WIRE)--#Biotech--Eikon Therapeutics Inc., a California-based biotechnology company that applies advanced engineering and high-performance computing to the identification of important new medicines, today announced the appoint...
FRANKLIN, Tenn.--(BUSINESS WIRE)--Community Health Systems, Inc. (NYSE: CYH) announced today that its affiliated hospitals offering obstetrics services have deployed PeriWatch Vigilance, an artificial intelligence-based maternal-fetal early warning sys...
Reported positive primary endpoint results from pivotal trial of BT-001 after 90 days of treatment for type 2 diabetes Represents a first-in-class randomized, controlled clinical trial of a prescription digital therapeutic (PDT) for treating a cardio...
DUBLIN--(BUSINESS WIRE)--The "Global Hearing Aid Devices Market, By Type (Prescription-Based v/s Over-the-Counter), By style, By types of hearing loss, By Product type, by technology type, By patient type, By Distribution Channel, By Region, Competitio...
New report offers recommendations to build back better for CV-patients in Europe Cardiovascular population health can provide a key lever for boosting health system resilience and equity. BRUSSELS--(BUSINESS WIRE)--More than two years after the CO...
Dr. Collings brings her more than 30 years of experience to the telehealth leader. NORWALK, Conn.--(BUSINESS WIRE)--#behavioralhealth--Zillion announces the hiring of Dr. Cate Collings as their new Chief Medical Officer. With over 30 years experience ...
GPH101 for sickle cell disease granted U.S. FDA Fast Track Designation; dosing of first patient in Phase 1/2 CEDAR clinical trial on track for second half of 2022, with initial proof-of-concept data anticipated in 2023 Oral presentation highlighting ...
Press Ganey leaders unveil pivotal strategies for redesigning healthcare BOSTON--(BUSINESS WIRE)--Healthcare transformation isn’t going to happen overnight—it takes visionary leaders moving away from a hierarchical approach to a more engaged, equitabl...